cash & stock

Showing 1 posts of 1 posts found.

spark_logo

Spark Therapeutics buys Genable Tech for $6 million in cash and stock deal

March 11, 2016
Business Services, Medical Communications Genable Technologies, Spark Therapeutics, cash & stock, genetic technologies, merger & acquisitions

Spark Therapeutics (Nasdaq: ONCE) said it has acquired Ireland-based Genable Technologies, a privately-held gene therapy firm for $6 million in a cash …

Latest content